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Abstract
Background: Staphylococci belong to the most important pathogens causing implant-associated infections. Colonization of
the implanted medical devices by the formation of a three-dimensional structure made of bacteria and host material called
biofilm is considered the most critical factor in these infections. To form a biofilm, bacteria first attach to the surface of the
medical device, and then proliferate and accumulate into multilayered cell clusters. Biofilm accumulation may be mediated
by polysaccharide and protein factors.
Methology/Principal Findings: The information on Staphylococcus aureus protein factors involved in biofilm accumulation
is limited, therefore, we searched the S. aureus Col genome for LPXTG-motif containing potential surface proteins and chose
the so far uncharacterized S. aureus surface protein C (SasC) for further investigation. The deduced SasC sequence consists
of 2186 amino acids with a molecular mass of 238 kDa and has features typical of Gram-positive surface proteins, such as an
N-terminal signal peptide, a C-terminal LPXTG cell wall anchorage motif, and a repeat region consisting of 17 repeats similar
to the domain of unknown function 1542 (DUF1542). We heterologously expressed sasC in Staphylococcus carnosus, which
led to the formation of huge cell aggregates indicative of intercellular adhesion and biofilm accumulation. To localize the
domain conferring cell aggregation, we expressed two subclones of sasC encoding either the N-terminal domain including a
motif that is found in various architectures (FIVAR) or 8 of the DUF1542 repeats. SasC or its N-terminal domain, but not the
DUF1542 repeat region conferred production of huge cell aggregates, higher attachment to polystyrene, and enhanced
biofilm formation to S. carnosus and S. aureus. SasC does not mediate binding to fibrinogen, thrombospondin-1, von
Willebrand factor, or platelets as determined by flow cytometry.
Conclusions/Significance: Thus, SasC represents a novel S. aureus protein factor involved in cell aggregation and biofilm
formation, which may play an important role in colonization during infection with this important pathogen.
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Introduction
In the past two decades, Staphylococcus aureus has emerged one of
the most important pathogens causing infections with indwelling
medical devices, such as prosthetic joints, prosthetic heart valves,
intravascular catheters, and cerebrospinal fluid shunts, which
creates an increasing health care problem [1]. For example,
prosthetic joint infections occur at a frequency of 1.5–2.5% in
primary total hip or total knee arthroplasty with a mortality rate of
up to 2.5% [2]. By far the most frequently isolated species from
these infections are Staphylococcus species, i.e. S. aureus (22–39%) and
coagulase-negative staphylococci (15–37.5%) [2].
The pathogenesis of device-associated infections with staphylo-
cocciismainlycharacterizedbythepathogensabilitytocolonizethe
surfaces of the implanted medical device by the formation of a
three-dimensional structure of microorganisms embedded in a thick
extracellular matrix composed of polysaccharides, proteins, extra-
cellular DNA, and host factors, known as biofilm [3,4,5].
Microorganisms within a biofilm are protected against antimicro-
bial chemotherapy as well as against the immune system of the host.
Biofilm formation occurs in a two-step process. The first step
involves the adherence of the bacteria to artificial surfaces that can
occur either directly or via host factors acting as bridging
molecules, such as the extracellular matrix and plasma proteins
fibrinogen (Fg) and fibronectin (Fn) or platelets [6]. In the second
step, the bacteria proliferate and accumulate into a biofilm
requiring intercellular adhesion. Direct S. aureus adherence to the
unmodified artificial surface may be mediated by the major
autolysin Atl [7], which is highly homologous to the S. epidermidis
autolysin/adhesin AtlE shown to be involved in the attachment to
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typically belong to the family of microbial surface components
recognizing adhesive matrix molecules (MSCRAMM) are in-
volved in binding to host factor-coated foreign material, among
them Fn-binding proteins (FnBpA, FnBpB, Ebh), Fg-binding
proteins (ClfA, ClfB), collagen-binding protein (Cna), bone-
sialoprotein-binding protein (Bbp), and von Willebrand factor
(vWf)-binding protein A (Spa) [9,10,11,12,13,14,15,16]. Staphy-
lococcal biofilm accumulation is mediated by polysaccharide as
well as protein factors. The intercellular polysaccharide adhesin
(PIA), a b-1,6-N-acetylglucosaminoglycan [3], is produced by the
gene products encoded by the icaADBC operon that was first
identified in S. epidermidis [17] and is also present in S. aureus [18].
Surface proteins conferring biofilm accumulation include the
accumulation-associated protein (Aap) from S. epidermidis [19,20]
and the homologous S. aureus surface protein G (SasG) [21]. In S.
aureus, another protein, the biofilm-associated protein (Bap), is
involved in biofilm accumulation [22]. However, so far the bap
gene has not been found in any S. aureus isolate of human origin,
but has only been identified within bovine mastitis isolates [22].
A recent study demonstrated that all 18 S. aureus isolates from
prosthetic joint infections carry the icaADBC operon, produce PIA,
and are biofilm-positive [23]. Surprisingly, the biofilms of all 18 S.
aureus isolates could be almost completely eradicated by the
treatment with dispersin B (DspB), an enzyme with specific b-1,6-
hexosaminidase activity as well as by the treatment with trypsin
suggesting that both, proteinaceous adhesins and PIA contribute
to biofilm formation in these S. aureus isolates. This was in contrast
to S. epidermidis isolates from prosthetic joint infections. Only 62%
of the 52 S. epidermidis isolates carry the icaADBC operon and S.
epidermidis biofilms produced by icaADBC-positive strains were
disintegrated by DspB, but not by proteases. Furthermore, biofilms
produced by icaADBC-negative strains were disintegrated by
proteases, but not by DspB [23]. Thus, different mechanisms
seem to be involved in biofilm formation in clinical S. aureus- and S.
epidermidis-associated prosthetic joint infection isolates. More
specifically, in S. aureus-associated prosthetic joint infections,
polysaccharide and protein factors seem to act synergistically in
biofilm formation. Only 33% of the analyzed S. aureus strains carry
the sasG gene and none of them carry the bap gene, indicating the
existence of further, not yet identified surface proteins involved in
biofilm accumulation of S. aureus.
Upon a search for LPXTG-motif containing surface-anchored
proteins encoded by the S. aureus Col genome (http://www.tigr.
org), we chose to study the so far uncharacterized SasC. We
heterologously expressed sasC from S. aureus Col and from the
clinical S. aureus isolate 4074 in Staphylococcus carnosus under the
control of a xylose-inducible promoter. S. carnosus expressing sasC
formed huge cell aggregates indicative of intercellular adhesion,
which were disintegrated by protease treatment. Upon plasmid-
encoded expression of sasC, S. carnosus as well as S. aureus not only
formed huge cell aggregates, but also formed a much more
pronounced biofilm in microtiter plates as well as in glass tubes
than the respective wild-type strains. The domain conferring cell
aggregation and biofilm formation was localized to the N-terminal
domain of SasC. In conclusion, we identified SasC as a novel S.
aureus factor involved in intercellular adhesion and biofilm
accumulation.
Results
Identification and cloning of the sasC gene of S. aureus
As a candidate gene conferring biofilm formation in S. aureus,w e
amplified a DNA fragment containing the sasC gene including the
ribosome binding site by polymerase chain reaction (PCR) from S.
aureus 4074 and S. aureus Col genomic DNA using the primers
CHsasCfor and CHsasCrev yielding 6577 bp DNA fragments.
The DNA fragments were cloned into the BamHI and SmaI sites of
the vector pCX19 in S. carnosus, creating plasmids pSasC4074 or
pSasCCol.
Nucleotide sequence of sasC and amino acid sequence
analysis of the deduced protein
The nucleotide sequence of the cloned sasC gene from S. aureus
4074 was determined on both strands. sasC consists of 6558
nucleotides and encodes a deduced protein of 2186 amino acids
(aa) with a predicted molecular mass of 237.9 kDa. The ATG start
codon is preceded by a putative ribosome binding site at a distance
of 8 bp. Putative 210 (TATATT, nucleotides 261 to 256) and
235 (TAAACA, nucleotides 280 to 275) promotor sequences
were deduced from homologous DNA sequences from strain S.
aureus Col. A putative r-independent terminator consisting of two
stem-loops is located downstream of the TAA stop codon. The
deduced SasC sequence contains a putative signal peptide in the
first 37 aa that contains an YSIRK motif, which seems to play a
role in signal peptide processing [24]. The predicted sasC gene
product is composed of 25.1% hydrophobic, 12.1% basic, and
13.2% acidic aa. The theoretical pI value of SasC is 5.08. The
deduced aa sequence of SasC of strain 4074 shares 97% identical
aa with homologous proteins from strains S. aureus MW2 [25] and
MSSA476 [26], 96% identical aa with strains USA300 [27], COL
[28], Newman [29], NCTC8325 (accession number: Q2FXH4
[30]), and N315 [31] and 89% identical aa with strain MRSA252
[26]. Besides, SasC shares 31% identical aa with Mrp and FmtB
proteins from strain Col that have been implicated in methicillin-
resistance [32,33].
Sequence comparison of the deduced SasC sequence with
known protein sequences in databases revealed a domain structure
of SasC (Fig. 1A). The central portion of SasC contains a domain,
which is similar to the motif found in various architectures
(FIVAR; 54 aa, starting at N-590 and ending at D-643). The
FIVAR domain is followed by 17 direct repeated sequences of 72
aa each separated by a stretch of 5 aa, which are homologous to a
domain of unknown function (DUF1542) also found in other cell
surface proteins. The first DUF1542 repeat starts at Q-671 and
the last ends at I-1974. The DUF1542 repeats share between 18
and 47% identical aa (Fig. 1B). The FIVAR motif and the
DUF1542 domain are also present within Mrp and FmtB (see
above) as well as within the cell surface protein Ebh from S. aureus
[10] and the homologous Embp from S. epidermidis [34].
SasC mediates strong cell aggregation in S. carnosus
After overnight growth in tryptic soy (TS) broth supplemented
with 1% xylose, S. carnosus expressing sasC formed huge cell
clusters that were visible macroscopically (Fig. 2A) and micro-
scopically (Fig. 2C). In contrast, the strains did not form cell
clusters without induction by xylose (Fig. 2A). The cell clusters
were dissolved upon treatment with trypsin (Fig. 2B and C) or
proteinase K (Fig. 2B). Disruption of cell clusters by trypsin was
concentration-dependent (Fig. 2C).
Characterization of S. carnosus and S. aureus expressing
sasC or sasC-subclones
In order to dissect the functional domains within SasC, we
constructed subclones of sasC expressing either the N-terminal
domain including the FIVAR motif (subclone 1) or 8 of the 17
DUF1542 repeats (subclone 2) in S. carnosus yielding S. carnosus
Staphylococcus aureus Biofilms
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inverse PCR with the plasmid pSasC4074 as a template was
carried out for the construction of subclone 1 and subclone 2 by
using the primers CHsasCSub1rev/CHsasCSub1for and CHsasC-
Sub2rev/CHsasCSub2for, respectively.
The resulting PCR fragments were ligated and subsequently, S.
carnosus was transformed with the ligation mixtures. Correct clones
were verified by PCR and DNA sequencing. However, DNA
sequence analysis of subclone 1 revealed a 33-bp deletion in the C-
terminal region so that aa T-654 is fused to N-1987 rather than to
D-1976 (Fig. 1A). To functionally characterize sasC also in the S.
aureus background, we transformed S. aureus 4074 and S. aureus
SH1000, which is a 8325-4 derivative reconstituted for its rsbU
mutation [35], with the plasmids pSasC4074, pSasCsub1, or
pSasCsub2 leading to overexpression of sasC and its subfragments
in these strains.
To verify the production of the whole SasC or the truncated
SasC proteins, cell lysates of the strains were prepared and
analyzed by SDS-PAGE (Fig. 3A). S. carnosus and the S. aureus
strains expressing sasC revealed an additional protein band
corresponding to the size of SasC of 238 kDa. The strains
expressing subfragments 1 or 2 revealed additional protein bands
at 93 or 96 kDa, respectively. The strains expressing sasC or the
subfragments 1 or 2 were further characterized.
Figure 1. Schematic model of SasC and amino acid alignment of the DUF1542 repeats. A: Model of SasC. The positions of the N-terminal
signal peptide including the YSIRK motif, the C-terminal LPXTG motif, the FIVAR motif (aa N-590 to D-643), and the 17 DUF1542 repeats (aa Q-671 to I-
1974) are indicated. The DUF1542 repeats consist of 72 aa each separated by 5 aa. The SasC domains expressed by subclone 1 (aa T-654 is fused to N-
1987) and subclone 2 (aa T-40 is fused to E-1359) are indicated. The SasC domain expressed as His-tagged fusion protein is shown: His-DUF1542 (aa
Q-902 to Q-1515). + indicates cell aggregation mediated by the respective clone; 2 indicates no cell aggregation. B: Alignment of the deduced amino
acid sequences of the DUF1542 repeats. The consensus sequence indicates the DUF1542 domain (Pfam accession number: PF07564). Bold letters
indicate amino acids that match the consensus sequence. Asterics indicate identical amino acids, colons indicate very similar amino acids. Gaps
(dashes) were filled in to maximize homologies.
doi:10.1371/journal.pone.0007567.g001
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In contrast to the wild-type strains, S. carnosus (pSasC4074), S.
aureus 4074 (pSasC4074) and S. aureus SH1000 (pSasC4074) as well
as S. carnosus (pSasCsub1) and S. aureus SH1000 (pSasCsub1)
formed huge cell aggregates that were visible macroscopically in
cultures grown overnight on TS agar supplemented with 1%
xylose and resuspended in PBS on glass slides (Fig. 4). The cell
aggregates formed by S. aureus 4074 (pSasCsub1) were somewhat
smaller in size (comparable to those mediated by the icaADBC
operon encoding the production of the polysaccharide intercellular
adhesin, PIA [17] Fig. 4–13) corresponding to a lower expression
level of the fusion protein (see Fig. 3). In contrast, the parent
strains or strains expressing the subfragment 2 did not form visible
cell aggregates (Fig. 4). Thus, sasC and its subfragment 1 confer cell
aggregation.
(ii) Biofilm formation on polystyrene and glass
Biofilm formation on polystyrene was determined in the
quantitative biofilm assay. Whilst S. carnosus (pCX19) revealed a
biofilm-negative phenotype (A490 value: 0.11), S. carnosus
(pSasC4074) and S. carnosus (pSasCSub1) showed an enhanced
biofilm formation corresponding to an A490 value of 0.43 and 0.4
(Fig. 5A). In contrast, biofilm formation of strain S. carnosus
(pSasCsub2) is comparable to that of the wild type (A490 value: 0.05).
In S. aureus, the expression of sasC or the subfragment 1 also led
to a markedly increased biofilm formation as shown for strain
SH1000 [A490 value of 1.5 or 1.4 for S. aureus SH1000
(pSasC4074) or S. aureus SH1000 (pSasCsub1), respectively, versus
A490 value of 0.7 for S. aureus SH1000] (Fig. 5A). As observed with
S. carnosus, the biofilm formation of S. aureus SH1000 (pSasCsub2)
is comparable with that of its wild type (A490 value: 0.8). The
results for S. aureus 4074 are similar (not shown).
The stronger capacity for biofilm formation mediated by sasC or
the subfragment 1 also could be observed on a glass surface with S.
carnosus as well as with S. aureus SH1000 (Fig. 5B) and S. aureus 4074
(not shown) and was comparable with that of S. carnosus (pCN27)
producing PIA [17] (Fig. 5B). Thus, sasC and its subfragment 1
mediate biofilm formation on polystyrene and on glass.
(iii) Initial attachment to polystyrene and to glass
Bacterial biofilm formation results from initial attachment of
bacterial cells to a surface and subsequent accumulation into
multilayered cell clusters, which requires intercellular adhesion
visible as cell aggregation. To determine, whether sasC not only
mediates cell aggregation, but also initial attachment, we analyzed
the capacity of the respective strains for attachment to a
polystyrene or a glass surface. Initial attachment of S. carnosus
(pCX19) to polystyrene was very low indicated by a low number of
Figure 2. SasC-mediated cell aggregation of S. carnosus. Cell aggregation is visible macroscopically (A, B) and microscopically (C) and is
protease-sensitive (B, C). A: Visible cell cluster formation in liquid medium. Strains were incubated overnight in TSB with (B) or without (A) 1% xylose
with shaking. The cells were harvested by centrifugation, resuspended in PBS, and observed in the wells of 24-well microtiter plates. 1: S. carnosus
(pCX19); 2, S. carnosus (pSasCCol); 3, S. carnosus (pSasC4074). B: After overnight growth in TSB with 1% xylose, S. carnosus cells were treated for 3 h at
37uC with PBS (A), 2.5 mg/ml trypsin (B), or 2 mg/ml proteinase K (C). 1: S. carnosus (pCX19); 2, S. carnosus (pSasCCol); 3, S. carnosus (pSasC4074). C:
Phase-contrast micrographs. Cells were treated overnight at 37uC with different concentrations of trypsin (0.25 mg/ml, 3; 0.5 mg/ml, 4; 1.25 mg/ml, 5;
2.5 mg/ml, 6) or left untreated (1, 2). 1: S. carnosus (pCX19); 2–6: S. carnosus (pSasC4074).
doi:10.1371/journal.pone.0007567.g002
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subfragments showed higher initial attachment with S. carnosus
(pSasCsub1) yielding the highest numbers of attached bacteria
(Fig. 6A). Essentially the same was observed with S. aureus SH1000
strains albeit at a higher level of attachment (Fig. 6A) and with S.
aureus SH1000 (pSasCsub2) showing numbers of attached bacteria
that were comparable with the wild type.
Initial attachment of the strains to a glass surface generally was
higher (Fig. 6B) and similar with S. carnosus and S. aureus SH1000
wild-type strains and the same strains expressing sasC or the
subfragment 2. In contrast, both strains expressing subfragment 1
showed a slightly lower number of attached bacterial cells (Fig. 6B).
Thus, expression of sasC slightly increased attachment to a
polystyrene surface, but did not increase attachment to glass.
(iv) Binding to Fg, vWF, thrombospondin-1 (TSP-1), and
platelets
The ability of S. aureus to bind to extracellular matrix and plasma
proteins and to host cells determines its capacity for tissue
colonization. The potential of sasC to mediate binding to the
extracellular matrix and plasma proteins Fg, TSP-1, and vWf as well
as to platelets was analyzed by flow cytometry. While S. aureus 4074
bound to Fg, TSP-1, and vWf as well as to activated platelets in a
dose-dependent fashion, S. carnosus, S. carnosus (pSasC4074), and S.
carnosus (pSasCsub2) did not (Fig. 7). Thus, sasC does not mediate
binding to these extracellular matrix proteins or to activated platelets.
Biofilm formation of a sasC transposon (Tn)917 insertion
mutant (SMH2035)
To further support the role for SasC in biofilm formation, we
analyzed the capacity of a sasC Tn917 insertion mutant (SMH2035)
for biofilm formation in comparison to its wild-type strain S. aureus
SH1000. Under all conditions tested, the sasC mutant strain showed
reduced biofilm formation in microtiter plates, i.e. the addition of
1%xylose[A490 value of0,4forSMH2035versus A490 value of0,7
for SH1000], 0.25% glucose [A490 value of 1,6 for SMH2035
versus A490 value of 1,8 for SH1000] or no additional carbohydrate
source in the biofilm assay [A490 value of 0,5 for SMH2035 versus
A490 value of 1,0 for SH1000] (Fig. 8). The biofilm-forming
capacity of both strains was most pronounced upon addition of
0.25%glucose,whichisknowntoinducetheproductionofPIAinS.
epidermidis [36] and probably leads to enhanced PIA production also
in S. aureus, which might partially obscure the function of SasC. The
presence of 1%xyloseseems to slightly reduce biofilm formation.So
far, the reason for this is unknown.
Expression and purification of the 6 x Histidine (His)-
DUF1542 fusion protein in Escherichia coli
For expression of the sasC portion encoding 8 of the 17
DUF1542-repeats in E. coli, the PCR-amplified fragments were
cloned into the expression vector pQE30Xa. One representative
clone expressing the DUF1542 repeats (6 x His-DUF1542)
contained the plasmid pHis-DUF1542. Subsequently, the 6 x
His-DUF1542 fusion protein was purified from E. coli (pHis-
DUF1542) via its His-tag using Ni-NTA affinity chromatography
under native conditions. SDS-PAGE of the affinity-purified fusion
proteins revealed an approximately 70-kDa protein for the 6 x
His-DUF1542 fusion protein (Fig. 3B). A protein with the same
size was present in cell lysates of an induced culture of E. coli (pHis-
DUF1542) and absent from cell lysates of an induced culture of E.
coli (pQE30) (not shown) and of a non-induced culture of E. coli
(pHis-DUF1542) (Fig. 3B).
Figure 3. Expression of sasC or sasC subfragments. A: SDS-PAGE (10% separation gel) of cell lysates of S. carnosus or S. aureus expressing sasC or
sasC subfragments. The lanes contained: 1, 10, 15, marker proteins; 2, S. carnosus (pCX19); 3, S. carnosus (pSasC4074); 4, S. carnosus (pSasCsub1); 5, S.
carnosus (pSasCsub2); 6, S. aureus SH1000; 7, S. aureus SH1000 (pSasC4074); 8, S. aureus SH1000 (pSasCsub1); 9, S. aureus SH1000 (pSasCsub2); 11, S.
aureus 4074; 12, S. aureus 4074 (pSasC4074); 13, S. aureus 4074 (pSasCsub1); 14, S. aureus 4074 (pSasCsub2). The sizes of marker proteins are shown
on the left (prestained protein ladder; Fermentas, Leon-Rot, Germany); in the right margin the sizes (kilodaltons) of SasC and truncated SasC proteins
are indicated. B: Expression and purification of 6 x His-DUF1542. SDS-PAGE (10% separation gel) of crude cell lysates from non-induced E. coli (pHis-
DUF1542) (lane 2), IPTG-induced E. coli (pHis-DUF1542) (lane 3), and purified 6 x His-DUF1542 (1.5 mg) (lane 4). The size of one marker protein is
shown on the left (lane 1; prestained protein ladder, Fermentas).
doi:10.1371/journal.pone.0007567.g003
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To detect the surface location of SasC, the antiserum against the
6 x His-DUF1542 fusion protein that was raised in rabbits was
used in immunofluorescence microscopy. The anti-His-DUF1542
antiserum strongly reacted with cells of S. carnosus (pSasC4074)
(Fig. 9) and S. aureus 4074 (pSasC4074) (not shown) indicating the
cell surface location of SasC. With S. carnosus (pSasC4074), no
immunofluorescence was detected with the preimmune serum (not
shown) and with S. carnosus (pCX19), no immunofluorescence was
detected with the anti-His-DUF1542 antiserum (Fig. 9). However,
there was some immunofluorescence detectable with the pre-
immune serum and strain S. aureus 4074 (not shown), which may
be due to the IgG-binding and surface-associated proteins A and
Eap [37,38].
Characterization of sasC expression in S. aureus strains
To analyze the production of SasC in S. aureus, we performed
Western blot analysis using the anti-His-DUF1542 antiserum. In
cultures of S. aureus 4074, Col, and SH1000, a faint band
corresponding to SasC was detected in lysostaphin lysates of
cultures after 10, 16, 24, and 48 h of growth (not shown). A strong
production of SasC was observed in control strains S. aureus 4074
Figure 4. The N-terminal SasC domain, but not the DUF1542 repeats mediate cell aggregation. The strains were grown 24 h on TS agar
plates containing 1% xylose and 10 mg/ml chloramphenicol, when appropriate. Then, a loop of cell material was resuspended in PBS buffer on a glass
slide, viewed macroscopically and photographed against a dark background. 1, S. carnosus (pCX19); 2, S. carnosus (pSasC4074); 3, S. carnosus
(pSasCsub1); 4, S. carnosus (pSasCsub2); 5, S. aureus 4074; 6, S. aureus 4074 (pSasC4074); 7, S. aureus 4074 (pSasCsub1); 8, S. aureus 4074 (pSasCsub2);
9, S. aureus SH1000; 10, S. aureus SH1000 (pSasC4074); 11, S. aureus SH1000 (pSasCsub1); 12, S. aureus SH1000 (pSasCsub2); 13, S. carnosus (pCN27).
Large cell clusters are formed by strains expressing sasC and the subfragment 1, but not by strains expressing the subfragment 2.
doi:10.1371/journal.pone.0007567.g004
Staphylococcus aureus Biofilms
PLoS ONE | www.plosone.org 6 October 2009 | Volume 4 | Issue 10 | e7567(pSasC4074) and S. carnosus (pSasC4074), while no protein isolated
from S. carnosus (pCX19) reacted with the anti-His-DUF1542
antiserum (not shown). SasC did not react with the preimmune
serum (not shown).
Prevalence of sasC
To determine the prevalence of the sasC gene among clinical S.
aureus isolates, we performed PCR analysis using primers
CHsasC1for and CHsasC1rev. An approximate 500 bp fragment
encoding a portion of the N-terminal SasC domain was found to
be present in 97% (66/68) of the clinical S. aureus strains that were
tested (not shown). This indicates a very high prevalence of the
sasC gene among clinical S. aureus isolates.
Discussion
The most frequently isolated bacteria from implant-associated
infections are S. aureus and coagulase-negative staphylococci
causing significant morbidity and mortality. The pathogenicity of
these infections is characterized by the pathogens pronounced
ability to form biofilms. To date, several S. aureus genes have been
implicated in biofilm formation, among them atl [7], dltA [39], and
the icaADBC gene cluster [18]. S. aureus surface proteins reported to
be involved in biofilm formation include SasG [21], the Fn- and
Fg-binding proteins FnBPA and FnBPB [40], and the biofilm-
associated protein Bap [22]. SasG is homologous to the
accumulation-associated protein Aap, which mediates biofilm
accumulation in S. epidermidis [19,20], and the plasmin-sensitive
surface protein Pls [41], which so far has not been implicated in
biofilm formation. Furthermore, extracellular genomic DNA
(eDNA) has been established as another important component of
S. aureus biofilms [5]. eDNA is released from the bacteria by cell
lysis and may implicate an additional role for the major S. aureus
autolysin Atl in biofilm development besides its function in initial
attachment [5].
However, a recent study indicated the existence of further, yet
unidentified surface proteins contributing to S. aureus biofilm
formation [23]. As a potential candidate, we identified SasC in the
S. aureus genome and expressed its gene heterologously in S.
carnosus as well as in the S. aureus strains SH1000 and 4074 under a
xylose-inducible promotor. All strains expressing sasC showed a
high-level production of a protein with a molecular size of
approximately 240 kDa corresponding to SasC. Expression of sasC
led to strong cell cluster formation, intercellular adhesion, and
biofilm formation. Furthermore, a sasC Tn917 insertion mutant
(SMH2035) showed a reduced capability for biofilm formation in
comparison to its wild type.
SasG and Aap promote biofilm formation via their B-repeats.
Each B-repeat also known as G5 domain consists of 128 aa and is
present 7 and 5 times in SasG and Aap, respectively [20,21].
Recently, the G5 domains were found to be zinc-dependent
adhesion modulesanda ‘‘zinczipper’’mechanismwas suggested for
G5 domain-based intercellular adhesion in SasG- or Aap-mediated
biofilm accumulation [42]. SasC also contains a repeat region with
17 repeats of 72 aa being similar to the DUF1542 domain (see
Fig. 1). The SasC repeats do not share sequence similarities with the
B-repeats of SasG and Aap and are not involved in biofilm
formation. Instead in SasC, the domain conferring cell aggregation
and biofilm formation could be localized to the N-terminal domain
by subcloning experiments (see Fig. 1).
Furthermore, SasG and Aap must undergo proteolytic cleavage
to become active, while SasC-mediated biofilm formation does not
depend on proteolytic cleavage: the formation of SasC-mediated
biofilms was unchanged in the presence of the protease inhibitor
a2-macroglobulin (data not shown) that blocked SasG and Aap-
mediated biofilm formation [20,21]. Moreover, S. carnosus
expressing aap only formed a detectable biofilm after treatment
with 2 mg/ml of trypsin leading to the production of a truncated
version of Aap or when an N-terminally truncated version of aap
was cloned in S. carnosus [20]. In contrast, no truncation of SasC
was involved in SasC-mediated biofilm formation. Thus, the
mechanism of SasC-mediated biofilm accumulation clearly differs
from that mediated by SasG/Aap. Because of the lack of sequence
similarities, the SasC-mediated mechanism probably is also
distinct from that mediated by Bap [22].
Recently, a role for FnBPA and FnBPB in biofilm accumula-
tion, which is independent of their Fn- and Fg-binding activities
was reported. Like with SasC, the domain conferring biofilm
accumulation is located within the N-terminal domain (A domain),
which also includes the domain for Fg-binding. However, biofilm
formation seems to be independent of Fg-binding, because a single
aa exchange within that region abolished Fg-binding, but did not
influence the capability for biofilm formation [40]. Because the
FnBPs and SasC do not share significant sequence similarities
within their N-terminal domains, the mechanism of biofilm
accumulation between the two also seems to differ.
The N-terminal SasC domain shows significant homology to the
N-terminal domains of Mrp and FmtB, both of which have been
reported to be involved in methicillin resistance [32,33]. However,
the mechanism of Mrp and FmtB conferring methicillin resistance
is not completely clear yet and may be indirect. A function of these
proteins in biofilm formation has not been proposed so far.
The mechanism of SasC-mediated biofilm accumulation is not
known yet and may involve either protein-protein interactions
Figure 5. SasC-mediated biofilm formation of S. carnosus or S.
aureus strains. A: Quantitative assay of biofilm formation. Lanes: 1, S.
carnosus TM300 (pCX19); 2, S. carnosus (pSasC4074); 3, S. carnosus
(pSasCSub1); 4, S. carnosus (pSasCSub2); 5, S. aureus SH1000; 6, S. aureus
SH1000 (pSasC4074); 7, S. aureus SH1000 (pSasCSub1); 8, S. aureus
SH1000 (pSasCSub2). B: Biofilm formation on glass. Lanes: 1, S. carnosus
TM300 (pCX19); 2, S. carnosus (pSasC4074); 3, S. carnosus (pSasCSub1);
4, S. carnosus (pSasCSub2); 5, S. aureus SH1000; 6, S. aureus SH1000
(pSasC4074); 7, S. aureus SH1000 (pSasCSub1); 8, S. aureus SH1000
(pSasCSub2); 9, S. carnosus (pCN27).
doi:10.1371/journal.pone.0007567.g005
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drate interactions conferred by the FIVAR motif. The FIVAR
motif is located at the C-terminus of the N-terminal domain (see
Fig. 1) and has been proposed to have a sugar-binding function.
Further analyses are necessary to elucidate these possibilities.
SasC not only mediates cell cluster formation and intercellular
adhesion, but also slightly increases the attachment of the cells to
polystyrene. Initial attachment to a polystyrene surface depends on
cell surface hydrophobicity [43,44]. With 25.1% hydrophobic aa,
the percentage of hydrophobic aa of SasC is comparable to that of
AtlE (26.4%) previously found to mediate initial attachment to
polystyrene in S. epidermidis [8]. Remarkably, the higher level of
initial attachment to polystyrene observed with S. carnosus and S.
aureus producing subclone 1 correlated with a higher percentage of
hydrophobic aa (28.1%) and a lower percentage of charged aa
(23.7%: 12.3% basic and 11.4% acidic aa) of subclone 1 in
comparison to subclone 2, which contains 26.6% hydrophobic aa
and 30.1% charged aa (14.7% basic and 15.4% acidic aa).
Although the S. aureus wild-type strains Col, SH1000, and 4074
all harbour the sasC gene, we were not able to detect SasC in
lysostaphin lysates by SDS-PAGE, but only by Western immuno-
blot analysis indicating very low sasC expression in vitro. However,
the identification of SasC as an in vivo-expressed antigen during
infection delineates its potential clinical significance [45]. Thus,
sasC expression may be induced in vivo. Several genes are involved
in the regulation of S. aureus biofilm formation, such as agr [46,47],
sarA [48,49], sigB [50], rbf [51], tcaR [52], arlRS [53], and alsSD
[54]. Further experiments are necessary to characterize the
expression of sasC.
Homologous sasC genes were found in the eight sequenced S.
aureus genomes analyzed and the sequence similarities of the SasC
gene products ranged from 89% to 97%. Consistently, we found a
very high prevalence of the sasC gene among clinical S. aureus
strains delineating the potential importance of SasC in coloniza-
tion and infection. In conclusion, we identified and characterized a
novel S. aureus surface protein, SasC, involved in cell aggregation
Figure 6. SasC-mediated initial attachment of S. carnosus or S. aureus strains. Phase-contrast micrographs of attached cells of S. carnosus
(TM300) or S. aureus (SH1000) strains on polystyrene Petri dishes (A) or on glass slides (B).
doi:10.1371/journal.pone.0007567.g006
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PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7567Figure 7. SasC does not bind to extracellular matrix proteins Fg, vWf, and TSP-1 or to platelets. Bars: black, S. aureus 4074; dark grey, S.
carnosus (pCX19); light grey, S. carnosus (pSasC4074); white, S. carnosus (pSasCsub2). Solid black line: S. aureus 4074; small dashed line: S. carnosus
(pCX19); dashed black line, S. carnosus (pSasC4074); dashed grey line, S. carnosus (pSasCsub2). The results represent the mean of three independent
experiments. Standard deviations are indicated.
doi:10.1371/journal.pone.0007567.g007
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colonization during infection with this important pathogen.
Materials and Methods
Ethics Statement
This study was conducted according to the principles expressed
in the Declaration of Helsinki. The study was approved by the
local ethics committee (Ethikkommission der Aertzekammer
Westfalen-Lippe und der Medizinische Fakultaet der WWU
Muenster) (reference number: Sitzung 19.05.1999). All volunteers
provided written informed consent for the collection of samples
and subsequent analysis.
Bacterial strains, plasmids, and media
The sasC gene was cloned from the clinical strain S. aureus 4074
[55] and from S. aureus Col [28]. S. carnosus TM300 [56], S. aureus
4074 [55], and S. aureus SH1000 [35] were used as cloning hosts.
The sasC Tn917 insertion mutant SMH2035 was isolated by
sequencing Tn insertion junctions from a Tn917 mutant library of
S. aureus SH1000, using direct sequencing from isolated genomic
DNA [57]. One of the mutants gave a junction sequence, which
mapped to an insertion point at 1812698 in the S. aureus N315
genome. This corresponded to inactivation of SasC at aa 934. E.
coli TG1 was used to construct the plasmid for the production of
the 6 x His-DUF1542 fusion protein and its purification.
For the expression of sasC in staphylococci, the vector pCX19, a
derivative of the xylose-inducible expression vector pCX15 [58]
and for the production and purification of the 6 x His-DUF1542
fusion protein, the Qiaexpress vector pQE30Xa (Qiagen) was used.
To determine the prevalence of sasC, a 489 bp internal sasC
fragment was amplified from genomic DNA of 68 clinical S. aureus
isolates obtained from patients at the University Hospital of
Mu ¨nster (Mu ¨nster, Germany).
The staphylococci were routinely cultivated in TS broth (TSB).
E. coli strains were grown in Luria-Bertani (LB) medium. TS and
LB agar contained 1.4% agar. TSB and TS agar were
supplemented with 1% xylose to induce sasC expression. Selection
for resistance to antibiotics in E. coli was performed with 100 mg/
ml ampicillin and in staphylococci with 10 mg/ml chloramphen-
icol or 5 mg/ml erythromycin, when appropriate. Wild-type strains
not harboring a plasmid were grown in the presence of 0.07%
ethanol in the respective assays, when compared to the strains
harboring a plasmid to rule out an effect of the ethanol. Because
Figure 8. S. aureus SH1000 sasC shows reduced biofilm formation. Quantitative assay of biofilm formation. Lanes: 1, S. aureus SH1000; 2, S.
aureus SH1000 sasC. A, 1% xylose; B, 0.25% glucose; C, no additional carbohydrate source.
doi:10.1371/journal.pone.0007567.g008
Figure 9. Detection of SasC by immunofluorescence microscopy. Strains grown in TSB were incubated with anti-His-DUF1542 antiserum
raised in rabbits. Bound antibodies were detected with fluorescein-conjugated anti-rabbit F(ab9)2 fragment. Cells were viewed with a fluorescence
microscope. S. carnosus (pSasC4074) cells reacted with the anti-His-DUF1542 antiserum, indicating the surface location of SasC. Magnification,6400.
A, S. carnosus (pSasC4074); B, S. carnosus (pCX19).
doi:10.1371/journal.pone.0007567.g009
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or ethanol was included in the assays comparing the SH1000
strain and its sasC mutant.
Bovine serum albumin (BSA) and a-thrombin (bovine) were
purchased from Sigma. Human Fg was purchased from Enzyme
Research Labs. The monoclonal antibody against human CD42a
(GP IX) (conjugated with phycoerythrin [PE]) was delivered by
Exalpha via NatuTec. Syto 13 for labeling of staphylococcal cells
was purchased from Molecular Probes via Mobitec.
DNA manipulations, transformation, PCR, DNA
sequencing, websites, and Pfam accession numbers
DNA manipulations and transformation of E. coli were
performed according to standard procedures [59]. S. carnosus and
S. aureus strains were transformed with plasmid DNA by protoplast
transformation [60]. Plasmid DNA was isolated using the Qiagen
Plasmid Kit and chromosomal DNA was isolated using the
QIAamp DNA Blood Mini Kit according to the instructions of the
manufacturer (Qiagen). PCR was carried out with the PCR
Supermix High Fidelity (Invitrogen) or with the Expand Long
Template PCR System (Roche, Mannheim, Germany) in
accordance with the protocol of the supplier. The primers (see
Table 1) were synthesized by MWG-Biotech (Ebersberg,
Germany).
The DNA sequence of both strands of the sasC gene of the
clinical isolate S. aureus 4074 was determined by MWG-Biotech
using a LI-COR DNA sequencer.
The DNA and deduced protein sequences were analyzed using
the program ‘‘JustBio’’ at http://www.justbio.com. The protein
sequences were compared with those of known proteins using the
programs BLASTP [61] and FASTA [62]. The alignments were
done using the program ClustalW at the European Bioinformatics
Institute (EBI, Cambridge, UK). The Pfam accession numbers are:
PF04650 for the YSIRK_signal; PF07554 for the FIVAR motif;
PF07564 for the DUF1542 domain; PF00746 for the Gram_
pos_anchor (LPXTG_anchor) available at: http://pfam.sanger.ac.
uk/ [63]. The signal peptide of SasC was predicted by using the
program ‘‘SignalP’’ at http://www.cbs.dtu.dk/services/SignalP/).
Biofilm formation assay
For quantification of the biofilm-forming capacity, a test for
biofilm production was performed essentially as described
previously [44]. Briefly, strains were grown in TSB supplemented
with 1% xylose for 24 h at 37uC in 96-well polystyrene microtiter
plates (cell star; Greiner, Frickenhausen, Germany), the wells were
washed with phosphate-buffered saline (PBS) and adherent
biofilms were stained with 0.1% safranin (Serva). In some
experiments, instead of 1% xylose, 0.25% glucose or no additional
carbohydrate source was added. Absorbance was measured with a
Micro-ELISA-Autoreader at 492 nm. Strains were tested at least
in triplicate. Determination of biofilm formation on a glass surface
was carried out essentially in the same way, except that glass tubes
were used instead of microtiter plates and 5 ml of TSB were
inoculated instead of 200 ml.
Initial adherence to a polystyrene or a glass surface
Initial cell attachment was tested as described previously [44].
Briefly, diluted cell suspensions of bacteria in PBS were incubated
for 30 min in polystyrene Petri dishes (Sarstedt) at 37uC or on glass
slides and after a washing procedure, attached bacteria were
evaluated by phase-contrast microscopy.
Construction and purification of the 6 x His-DUF1542
fusion protein and anti-His-DUF1542 antiserum
For the construction of the His-tagged fusion protein, the
primers CHsasCDUFfor and CHsasCDUFrev were used to
amplify 8 of the DUF1542-repeats of sasC from genomic DNA
Table 1. Oligonucleotide primers used in this study.
Primer name Oligonucleotide sequence (59R39)
CHsasCfor GTG AGA TCT CCA GGA GGA AAA CGA AAT GAA TTT G (BglII) cloning sasC
CHsasCrev CGT GGG CCC AAT TAT GAT TCT TTT TCG TTT TTA GTA CG C (SmaI) cloning sasC
CHsasCDUFfor CAA CAT ATC GCA GAG ATC AAT G expression
CHsasCDUFrev GTG GGA TCC TTA TTG TTG CTT AAC TGC ATC TCT AGC (BamHI) expression
CHsasCSub1rev CGT ATG TTG CAT TTG ATT AG subcloning sasC
CHsasCSub1for GAT GAT CTT GCA CGC GTC AC subcloning sasC
CHsasCSub2rev CGT AGT TAA GGC TTG TGC ACC subcloning sasC
CHsasCSub2for GAA AAA GCT GTT AAA GAA AAG subcloning sasC
CHsasC1for GCA ACG AAT CAA GCA TTG G prevalence
CHsasC1rev TGA CAG CAC TTC GTT AGG prevalence
pCX19for CTA AAT CGA TTT CTG GCC C sequencing
SasC60for GTATTAGGAAGTATAAAGTAGG sequencing
SasC700for CCA ACA ACT GAT CCT AAT GCC sequencing
Sub1SasC4620rev CAT CAG TCG CAT GTT CCG C sequencing
Sub2SasC1380for GAATAATGGTAATTCTGGTG sequencing
SasC840rev CCATTGATTAGTGTGAAGCCC sequencing
SasC2100rev CCT CGA TAA CTT GTA TTG CTG C sequencing
SasC3860for GGC GAA GCG TAT TGA AGC GG sequencing
SasC5040for GAT GCA ATC CGA AAT ACG TTG G sequencing
doi:10.1371/journal.pone.0007567.t001
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amplified fragment was cloned into the vector pQE30Xa, so that
the gene fragment is in frame with the His-codons. One
representative clone expressing the DUF1542-repeats was desig-
nated E. coli (pHis-DUF1542) (see Fig. 1). The 6 x His-DUF1542
fusion protein was purified under native conditions via its His-tag
using Ni-NTA affinity chromatography (Ni-NTA Spin Kit;
Qiagen) according to the protocol of the suppliers (see Fig. 3B).
The yield of the 6 x His-DUF1542 fusion protein was in the range
of 150 mg per 10 ml culture volume as determined by the
Coomassie Plus
TM Protein Assay (PIERCE, Rockford, IL, USA
distributed by Perbio Science, Bonn, Germany). The purified 6 x
His-DUF1542 fusion protein was used to immunize rabbits by
Eurogentec (Belgium) according to their standard immunization
program.
Protein isolation, SDS-PAGE, and Western blot analysis
Staphylococcal surface proteins covalently linked to the
peptidoglycan were prepared from cultures that were grown
overnight in TSB broth at 37uC by lysostaphin treatment. For this,
the staphylococcal cells were harvested by centrifugation, washed
and then, the cell pellet was resuspended in 20 ml Tris-buffered
saline (TBS) pH 7,4 per g bacteria. After adding 500 mg
lysostaphin (Ambi Products LLC, Lawrence, NY, USA; distribut-
ed by WAK Chemie, Steinbach, Germany) and 100 mg DNAse
(Sigma) per g bacteria, the suspension was incubated at 37uC with
shaking. Afterwards, the cell debris was removed by centrifugation
(45 min, 13.000 rpm, 4uC). Lysostaphin lysates were stored at
220uC. Crude cell lysates of E. coli (pHis-DUF1542) were
prepared from non-induced and induced (addition of 1 mM
Isopropyl-b-D-thiogalactoside [IPTG] and continued growth of
4 h) cultures by harvesting the cells, resuspending the cell pellet in
sample buffer, and heating the suspension for 5 min at 95uC.
Additionally, as a negative control, a crude cell lysate was
prepared from an induced culture of E. coli (pQE30). After
centrifugation, 7 ml of the cell lysates from E. coli,9ml of the
staphylococcal cell lysates, or 2 ml of the purified protein
(containing 1.5 mg) were subjected to SDS-PAGE (10% separation
gel and 4.5% stacking gel). Proteins were stained with Coomassie
brilliant blue R250 (0.1%).
For Western immunoblot analysis, staphylococcal surface
proteins, crude cell lysates, or purified proteins were prepared
and separated by SDS-PAGE as described above and transferred
to a nitrocellulose membrane (Schleicher and Schuell, Dassel,
Germany). The membranes were then blocked in Tris-buffered
saline (TBS)/3% BSA (overnight) and washed three times with
TBS/0.5% Tween 20 (TBST). Afterwards, the nitrocellulose
membranes were incubated for 2 h with the anti-His-DUF1542
antiserum diluted 1:2000 in TBST/3% BSA. As a negative
control, incubation was performed in TBST/3% BSA with
(1:2000) or without preimmune serum. The reaction of proteins
with specific antibodies was detected by incubation (1 h) with anti-
rabbit immunoglobulin G (IgG)/alkaline phosphatase (AP)
conjugate (Dako GmbH, Hamburg, Germany) diluted 1:5000 in
TBST/3% BSA and subsequent color reaction.
Purification and fluorescence-labelling of Fg,
thrombospondin-1 (TSP-1), or von Willebrand factor
(vWF)
Labelling of Fg was performed as described previously [64].
TSP-1 in an adhesive conformation was purified from freshly
isolated human platelets as described before [65]. For labelling
TSP-1 with fluorescein-isothiocyanate (FITC) (Calbiochem; La
Jolla, CA, USA), FITC was added to TBS/2 mM CaCl2
containing TSP-1 in a molar ratio of 600:1 and incubated for
24 h at 4uC. Unbound label was removed using a Sephadex G-25
PD-10 column equilibrated with TBS. The concentration of
FITC-labeled TSP-1 was determined by using the Pierce BCA
protein assay (Pierce Europe B.V., BA oud-Beijerland, The
Netherlands) according to the manufacturers instructions. vWf
was purified and labeled according to Hartleib et al [66].
Flow cytometric analysis of Fg-FITC, TSP-1-FITC, or vWF-
FITC binding to staphylococci
Measurement of the binding of Fg-FITC, TSP-1-FITC, or vWf-
FITC to staphylococcal cells was analyzed as described before for
the binding of vWf-FITC to S. aureus [66]. Briefly, bacteria from an
overnight culture (120,000 cells/ml) were incubated with Fg-FITC,
TSP-1-FITC, or vWf-FITC (final concentrations 0, 50, or 100 mg/
ml) in TBS/2 mM CaCl2 for 10 min at room temperature. After
washing and sonication, bacteria (5,000 cells/determination) were
analyzed in a flow cytometer (Becton Dickinson, FACSCalibur
flow cytometer, Heidelberg, Germany) using an excitation wave
length of 488 nm at the FACSCalibur standard configuration with
a 530 nm bandpass filter. Data were obtained from fluorescence
channels in a logarithmic mode.
Preparation of platelets
Blood was taken from healthy adult volunteers who had not
taken any medication affecting platelet function for at least 2 weeks
before the study. Platelet-rich plasma (PRP) was prepared from
anticoagulated blood by centrifugation and the platelets were gel-
filtered on a Sephadex Cl-2B column [67]. To inhibit fibrin
polymerisation, experiments were performed in the presence of the
peptide GPRP (1.25 mM) as described previously [67]. The
platelets were labeled by incubation with a monoclonal anti-
CD42a (GP IX) antibody conjugated with PE at saturated
concentrations for 30 min.
Preparation of bacteria and flow cytometric
measurement of Staphylococcus-platelet associate
formation
Staphylococcus-platelet associate formation was measured essen-
tially as described before [68]. Briefly, bacteria grown over night
were washed in TBS, briefly sonicated, and diluted with TBS/
2 mM CaCl2 to 250,000 bacteria/ml. Bacteria were labeled with
the fluorescent dye Syto 13 (emission similar to FITC) at a
concentration of 2 mM for 10 min, washed in TBS and briefly
sonicated again.
Platelets were activated with a-thrombin at the given concen-
trations for 4 min and subsequently, labeled bacteria were added.
Bacteria and platelets (10:1) were coincubated for 15 min at room
temperature and conjugate formation was measured immediately
thereafter in a flow cytometer. Associates were identified by double
labelling with Syto 13 (FL-1, ‘‘FITC like’’ signal) and anti CD42a-
PE (FL-2, PE signal), and given as the rate of bacteria-positive
platelets. Given are the mean values of three independent
experiments.
Immunofluorescence microscopy
The detection of SasC by immunofluorescence microscopy was
performed essentially as described before [17]. Briefly, cultures
were grown aerobically in TSB for 16 h at 37uC. After washing,
aliquots (30 ml) were applied to glass slides. The slides were air-
dried and the bacteria were fixed by heat. The fixed cells were
incubated with anti-His-DUF1542 antiserum or preimmune
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washed 4 times with PBS, and then incubated with FITC-
conjugated anti-rabbit F(ab9)2 fragment diluted 1:500 for 1 h at
37uC in a humid chamber. The slides were washed twice with PBS
and twice with double-distilled water. Then, the slides were dried,
covered with fluorescent mounting medium (Dako, Hamburg,
Germany), and viewed with a fluorescence microscope (Zeiss,
Oberkochen, Germany).
Nucleotide sequence accession number
The EMBL/GenBank/DDBJ accession number of the sasC
DNA sequence of strain 4074 is FM202067.
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